估计2020年野生型SARS-CoV-2的澳大利亚住院比例和成本
Peter Markey1, Julianne Bayliss2, Daryl Jones3
1School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia; Alfred Hospital, Melbourne, Victoria, Australia.
Current problems in cardiology
|July 2, 2023
概括
这项关于澳大利亚维多利亚州SARS-CoV-2 (COVID-19) 野生型菌株的研究揭示了住院需求和相关住院费用. 调查结果提供了对最初的流行病严重程度和医疗保健资源需求的见解.
科学领域:
- 流行病学 流行病学
- 卫生经济学 卫生经济学
背景情况:
- SARS-CoV-2 (COVID-19) 流行病的初始阶段为全球医疗保健系统带来了独特的挑战.
- 澳大利亚暂时消除社区传播的经验为研究最初的流行病影响提供了独特的机会.
研究的目的:
- 为了记录和估计SARS-CoV-2野生型菌株的住院需求.
- 估计在最初的流行病阶段与COVID-19治疗相关的住院医院费用.
主要方法:
- 使用澳大利亚维多利亚州病例数据的回顾性队列研究 (2020年3月29日至12月31日).
- 分析住院需求,病例死亡率和住院住院费用.
主要成果:
- 经人口调整后的结果显示10.2%需要仅病房入院,1.0%需要ICU入院,1.0%需要具有机械通风的ICU.
- 总体病例死亡率为2.9%.
- 平均住院费用在22,714美元至57,100美元之间,仅限病房的住院费用为37,228美元至140,455美元,而ICU住院费用为37,228美元至140,455美元.
结论:
- 来自受控疫情期间的维多利亚州COVID-19数据为我们提供了有关大流行最初严重程度的宝贵见解.
- 该研究量化了显著的住院需求和相关的住院费用,为未来的公共卫生准备提供了信息.
更多相关视频
相关概念视频
Single Nucleotide Polymorphisms-SNPs
15.3K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.3K
Steps in Outbreak Investigation
154
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
154
Actuarial Approach
98
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
98


